Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Boehringer Ingelheim
McKinsey
Colorcon
Harvard Business School

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drug Price Trends for LATANOPROST


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for LATANOPROST

Average Pharmacy Cost for LATANOPROST

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LATANOPROST 0.005% EYE DROPS 17478-0625-12 2.19664 ML 2020-02-19
LATANOPROST 0.005% EYE DROPS 24208-0463-25 2.19664 ML 2020-02-19
LATANOPROST 0.005% EYE DROPS 59762-0333-02 2.19664 ML 2020-02-19
LATANOPROST 0.005% EYE DROPS 61314-0547-01 2.19664 ML 2020-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LATANOPROST

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LATANOPROST 0.005% SOLN,OPH Valeant Pharmaceuticals International 24208-0463-25 2.5ML 3.52 1.40800 ML 2017-09-29 - 2022-09-28 FSS
VYZULTA 0.024% SOLN,OPH Valeant Pharmaceuticals International 24208-0504-05 5ML 354.57 70.91400 ML 2018-07-20 - 2022-09-28 FSS
LATANOPROST 0.005% SOLN,OPH Valeant Pharmaceuticals International 24208-0463-25 2.5ML 2.53 1.01200 ML 2018-02-01 - 2022-09-28 FSS
VYZULTA 0.024% SOLN,OPH Bausch Health US, LLC 24208-0504-05 5ML 269.04 53.80800 ML 2019-01-01 - 2022-09-28 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
Mallinckrodt
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.